Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 May 28;17(20):2543-51.
doi: 10.3748/wjg.v17.i20.2543.

Hepatic stellate cells and innate immunity in alcoholic liver disease

Affiliations
Review

Hepatic stellate cells and innate immunity in alcoholic liver disease

Yang-Gun Suh et al. World J Gastroenterol. .

Abstract

Constant alcohol consumption is a major cause of chronic liver disease, and there has been a growing concern regarding the increased mortality rates worldwide. Alcoholic liver diseases (ALDs) range from mild to more severe conditions, such as steatosis, steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. The liver is enriched with innate immune cells (e.g. natural killer cells and Kupffer cells) and hepatic stellate cells (HSCs), and interestingly, emerging evidence suggests that innate immunity contributes to the development of ALDs (e.g. steatohepatitis and liver fibrosis). Indeed, HSCs play a crucial role in alcoholic steatosis via production of endocannabinoid and retinol metabolites. This review describes the roles of the innate immunity and HSCs in the pathogenesis of ALDs, and suggests therapeutic targets and strategies to assist in the reduction of ALD.

Keywords: Alcoholic liver disease; Endocannabinoid; Fibrosis; Hepatic stellate cell; Kupffer cell; Natural killer cell; Steatohepatitis; Steatosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Regulatory mechanisms of the hepatic lipogenesis and CB1 receptor expression via hepatic stellate cell-derived endocannabinoids/CB1 receptors and retinoic acid/retinoic acid receptor-γ in hepatocytes, respectively. CB1 R: CB1 receptor; AMPK: AMP-activated protein kinase; HSC: Hepatic stellate cell; 2-AG: 2-arachidonoylglycerol; SREBP-1: Sterol regulatory element-binding protein-1; FAS: Fatty acid synthase; RA: Retinoic acid; RAR: Retinoic acid receptor.
Figure 2
Figure 2
Mechanism of natural killer cell cytotoxicity against activated hepatic stellate cells. STAT: Signal transducer and activator of transcription; IFN: Interferon; NK: Natural killer; HSC: Hepatic stellate cell; MHC: Major histocompatibility complex; RAE1: Retinoic acid early inducible-1; RA: Retinoic acid; ADH: Alcohol dehydrogenase.
Figure 3
Figure 3
A model for chronic alcohol acceleration of liver fibrosis via inhibition of natural killer cell killing against hepatic stellate cells and suppressor of cytokine signaling 1 suppression of interferon-γ signaling in hepatic stellate cells. SEC: Sinusoidal endothelial cell; ADH: Alcohol dehydrogenase; HSC: Hepatic stellate cell; RA: Retinoic acid; RAE1: Retinoic acid early inducible-1; IFN: Interferon; NK: Natural killer; TGF: Transforming growth factor; SOCS1: Suppressor of cytokine signaling 1.

References

    1. O’Shea RS, Dasarathy S, McCullough AJ. Alcoholic liver disease. Hepatology. 2010;51:307–328. - PubMed
    1. Williams R. Global challenges in liver disease. Hepatology. 2006;44:521–526. - PubMed
    1. Jeong WI, Gao B. Innate immunity and alcoholic liver fibrosis. J Gastroenterol Hepatol. 2008;23 Suppl 1:S112–S118. - PMC - PubMed
    1. Purohit V, Gao B, Song BJ. Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res. 2009;33:191–205. - PMC - PubMed
    1. Schattenberg JM, Wang Y, Singh R, Rigoli RM, Czaja MJ. Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling. J Biol Chem. 2005;280:9887–9894. - PubMed

Publication types

MeSH terms